Skip to main content
All ETFs
Watch Compare

GIICX

ETF
GIICX · UNKNOWN · 686 holdings

Quick Summary

Price History

Concentration Risk

12,20% Broadly spread
Low risk High risk

The top 10 holdings only account for 12,20%. No single stock can meaningfully hurt this fund — you'd need a broad market selloff to see real damage.

Sector Allocation

Consumer Cyclical
0,32%
Healthcare
0,10%
Financial Services
0,05%

Top 10 Holdings

12,20% of fund
SAP SE SAP SE
1,59%
ASML Holding NV ASML Holding NV
1,46%
Roche Holding AG Roche Holding AG
1,23%
Nestle SA Nestle SA
1,22%
AstraZeneca plc AstraZeneca plc
1,21%
Novartis AG Novartis AG
1,15%
Shell plc Shell plc
1,15%
HSBC Holdings plc HSBC Holdings plc
1,15%
Siemens AG Siemens AG
1,04%
Commonwealth Bank of Commonwealth Bank of Australia
1,01%
Other positions
1,89%

All Holdings (686)

Top 10: 12,20% of fund
# Ticker Name Weight Shares Market Value
1 SAP SE SAP SE 1,59% 43.746 12,52 M
2 ASML Holding NV ASML Holding NV 1,46% 16.499 11,45 M
3 Roche Holding AG Roche Holding AG 1,23% 30.732 9,67 M
4 Nestle SA Nestle SA 1,22% 109.760 9,57 M
5 AstraZeneca plc AstraZeneca plc 1,21% 64.960 9,47 M
6 Novartis AG Novartis AG 1,15% 79.646 9,02 M
7 Shell plc Shell plc 1,15% 250.772 9,00 M
8 HSBC Holdings plc HSBC Holdings plc 1,15% 740.381 9,00 M
9 Siemens AG Siemens AG 1,04% 31.839 8,16 M
10 Commonwealth Bank of Commonwealth Bank of Australia 1,01% 70.107 7,96 M
Showing top 10 of 686 holdings · Listed: 98,11% · 1,89% in other positions

Koersdoel Analisten

Geen analistendekking beschikbaar

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: N/A · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) N/A
ROE N/A ROA N/A
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) N/A
ROIC N/A FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: N/A
Debt / Equity N/A Current Ratio N/A
Interest Coverage N/A Asset Turnover N/A
Working Capital N/A Tangible Book Value N/A

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: N/A · EV/EBITDA: N/A
P/E Ratio N/A Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield N/A
Market Cap N/A Enterprise Value N/A

Per Share

EPS: N/A · FCF/Share: N/A
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share N/A OCF / Share N/A
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: N/A · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion N/A
SBC-Adj. FCF N/A Growth Momentum N/A

Sectorvergelijking

vs ETF sector mediaan (25157 peers)
Metriek Aandeel Sector Mediaan
P/E
P/B
ROE %
Net Margin %
Rev Growth 5Y %
D/E